U.S. Life Sciences Stock News

FBI armor contract puts Cadre Holdings (CDRE) in focus Cadre Holdings (CDRE) is back on investor radar after subsidiary Safariland was selected as the ballistic panel provider for Predictive Ballistics' Overt Armor Kit under a five year, $61 million FBI contract. See our latest analysis for Cadre Holdings. Despite the FBI contract putting fresh attention on the business, Cadre Holdings’ share price is down 31% over the past 90 days and 27% year to date. However, the 3 year total shareholder...

Integra LifeSciences Holdings: Recent Performance Snapshot Integra LifeSciences Holdings (IART) has attracted fresh attention after a strong share price move over the past 3 months, with the stock up about 75%, alongside a monthly gain above 20%. See our latest analysis for Integra LifeSciences Holdings. While the recent 30 day share price return of 21.36% and 90 day share price return of 74.61% suggest strong short term momentum, the 3 year total shareholder return is down 58.17%, indicating...

Texas Attorney General Ken Paxton has opened a formal investigation into Celsius Holdings and its Alani Nu subsidiary over past marketing of high‑caffeine energy drinks to children and teenagers, following a lawsuit alleging a teenager’s death linked to excessive consumption. The probe puts Celsius’s youth‑oriented branding and safety claims under legal scrutiny, testing how its growth-focused marketing approach aligns with consumer protection standards. We’ll now examine how this...

DocuSign (DOCU) has kicked off Q1 2027 with total revenue of US$830.2 million and basic EPS of US$0.40, setting the stage for investors to reassess how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$763.7 million in Q1 2026 to US$830.2 million in Q1 2027, while basic EPS shifted from US$0.35 to US$0.40 over the same stretch, giving you a clear read on how sales and earnings are tracking into the new fiscal year as margins come under...

A law firm has opened an investigation into Roblox (NYSE:RBLX) over potential fraud, negligence, or other unlawful practices, raising fresh questions about governance and legal risk for the platform. Separately, Roblox is overhauling its discovery algorithm to emphasize deeper user engagement and long term retention instead of immediate monetization. The company is aiming to improve content quality and appeal more to adult users. Roblox runs a global user generated gaming and experiences...

In recent days, Artisan Partners’ Artisan Small Cap Fund began exiting its position in FTAI Aviation, citing concerns that the company’s valuation embeds optimistic assumptions about its longer-term opportunities, including the FTAI Power initiative. The fund highlighted that FTAI’s effort to repurpose aircraft engines for data center power generation could be a volatile and non-linear profit driver, adding uncertainty to the company’s evolving business mix. Next, we’ll examine how...

Over the past week, SEALSQ (NasdaqGS:LAES) has announced a majority stake in Wecan Group, the acquisition of Swiss photonics firm Miraex, and a lead investment role in EeroQ and Quobly funding rounds. These moves extend SEALSQ's reach across post quantum security, quantum processors, and AI driven compliance tools in both Europe and the US. The transactions are presented as completing SEALSQ's Quantum Sovereign Vertical Stack and shifting the company toward a broader quantum platform...

Amentum Holdings (AMTM) has just been added to the Fortune 500 at position 313, putting a spotlight on the company’s scale, global reach, and relevance for investors tracking large defense and engineering contractors. See our latest analysis for Amentum Holdings. Despite the Fortune 500 recognition, Amentum’s share price has been under pressure, with the 30 day share price return down 8.4% and the year to date share price return down 25.2%. However, the 1 year total shareholder return is...

Wondering if Lumentum Holdings at around US$863.66 is still offering value after a big run, or if the easy gains are behind it? This article walks through what that price might really imply. The stock is up 1.0% over the past week, while the past month shows an 8.5% decline, and the year to date move is 123.7% with a very large 1 year return and a more than 15x gain over 3 years. Recent attention on Lumentum Holdings has included ongoing coverage of its position in communications technology...

Federal Agricultural Mortgage Corporation (Farmer Mac) was recently upgraded to a higher analyst rating after a sustained rise in earnings estimates, while its board also declared an initial dividend of US$0.2769097 per share on its newly issued 6.875% Non-Cumulative Preferred Stock, Series I, for the period from May 19, 2026, to July 17, 2026, payable on July 17, 2026, to holders of record on July 1, 2026. This combination of an analyst upgrade and the launch of a new preferred dividend...

Recent performance snapshot for Natera (NTRA) Natera (NTRA) has been volatile in recent trading, with the stock down 3.1% over the past day and 3.6% over the past week, roughly flat over the past month, and up 8.7% over the past 3 months. Over longer horizons, Natera shows mixed results, with the stock down 5.9% year to date while delivering a 31.5% total return over the past year, a very large total return over the past 3 years, and a 107.3% total return over the past 5 years. See our latest...

Clearway Energy stock performance snapshot Clearway Energy (CWEN) has drawn investor attention after a mixed stretch in its share price, with the stock down 1.6% over the past day but up 3.2% over the past month. See our latest analysis for Clearway Energy. At a share price of $39.74, Clearway Energy has seen short term momentum cool with a 1-week share price return down 3.5%, even as the year to date share price return of 17.0% and 1-year total shareholder return of 37.1% point to stronger...

Recent performance snapshot for Omega Healthcare Investors Omega Healthcare Investors (OHI) has seen mixed share performance recently, with the stock up about 1.8% over the past day but down around 5% over the past week and 3% over the past month. Over longer periods, the stock shows a different pattern, with total return of about 26% over the past year and very large multiyear gains, including roughly 7x over three years and about 0.8x over five years. See our latest analysis for Omega...

Wondering if KeyCorp's share price still reflects good value after a strong run, or if most of the easy gains are behind it? This article walks through what the current valuation actually says. KeyCorp shares last closed at US$21.76, with the stock up 2.0% over the past week, slightly down 2.1% over the past month, up 3.7% year to date, and up 38.9% over the past year, while the 3 year and 5 year returns stand at 137.8% and 26.4% respectively. Recent price moves sit against a backdrop of...

Wondering if Valero Energy at about US$255.82 is still priced attractively after such a strong run, or if most of the easy value has already been realised. The stock has returned 4.5% over the last 7 days, 8.1% over the last 30 days, 54.8% year to date and 104.4% over the past year, so any view on future risk or opportunity really hinges on what you think it is worth today. Recent headlines have focused on Valero Energy within the broader energy sector, with attention on how refining focused...

SoundHound AI stock performance snapshot SoundHound AI (SOUN) has drawn attention after a sharp pullback, with the stock down 7.7% over the past day, 17.9% over the past week, and 21.1% over the past month. Shares are also down 8.4% over the past 3 months and 30.3% year to date. The company reports revenue of US$183.986 million and a net loss of US$168.261 million. See our latest analysis for SoundHound AI. The recent slide, including a year to date share price return down 30.3% and a 1 year...

ADC Therapeutics (ADCT) has drawn fresh attention after reporting statistically significant Phase 3 LOTIS-5 topline data for ZYNLONTA plus rituximab in relapsed or refractory diffuse large B cell lymphoma, including improved progression free survival versus standard therapy. See our latest analysis for ADC Therapeutics. Despite the encouraging LOTIS-5 data, the stock’s 1-day share price return fell 21.97%, extending a 7-day share price decline of 69.71% and a 1-year total shareholder return...

Simon Property Group stock snapshot Simon Property Group (SPG) has drawn investor attention after recent share price moves, with the stock closing at US$210.31 and posting gains over the past week, month and past 3 months. Over the past year, Simon Property Group has delivered a total return of 36.2%, while year to date the stock is up 14.3%. Multi year figures show total returns of 118.97% over 3 years and 104.45% over 5 years. See our latest analysis for Simon Property Group. With a recent...

If you are wondering whether Synopsys at around US$464.85 is priced for opportunity or already reflects high expectations, the key is to understand what different valuation tools actually say about the stock. Over shorter periods the picture has been mixed, with the share price down about 2.3% over the last week, down 7.8% over the last month, down 3.2% year to date, and down 4.4% over the last year. The 3 year and 5 year returns sit at 5.9% and 76.7% respectively. Recent coverage of...

Keel Infrastructure (NasdaqGM:KEEL) has completed an upsized US$400 million convertible senior notes offering, above the initial US$350 million target. The transaction is intended to fund capped call arrangements and support expansion of data center projects for AI and high performance computing workloads. The offering adds financial flexibility as Keel continues its shift from Bitcoin mining toward broader digital infrastructure. Keel is positioning itself as a digital infrastructure...

For investors wondering whether Brookfield Infrastructure at around US$41.31 offers value or is asking too much for its future, this breakdown is designed to help frame that question in a clear, practical way. The stock has been slightly softer over the last week, with a 0.5% decline, but has gained 4.6% over the past month. Year to date it is down 8.8% and it is up 5.7% over the last year, with a 2.1% decline over three years and a 7.3% gain over five years. Recent price moves sit against a...

Match Group (MTCH) is back in focus after reports of falling demand, weaker customer acquisition, and a sharp drop in average revenue per user over the past two years, which points to tougher sales conditions. See our latest analysis for Match Group. The stock has pulled back recently, with a 1-month share price return down 9.42% and a 7-day share price return down 4.73%. However, the 90-day share price return of 12.96% and 1-year total shareholder return of 10.67% suggest earlier momentum...

In recent days, 10x Genomics experienced an extended winning streak in its stock, lifting its market value by about US$1.10 billion even as commentators highlighted ongoing weakness in operating performance and financial condition. This sharp rerating, coming despite concerns about fundamentals and valuation, raises questions about how much of the positive sentiment is grounded in the company’s underlying business trajectory. We’ll now examine how this momentum-driven rally, despite weak...

Aurinia Pharmaceuticals (NasdaqGM:AUPH) reported new AURORA 1 Phase 3 data at EULAR 2026 showing LUPKYNIS reduced the risk of renal events or death in lupus nephritis. The findings were presented at a major international rheumatology congress, putting fresh clinical evidence for LUPKYNIS in front of global specialists. Tang Capital Management increased its stake in Aurinia, and senior company executives acquired additional shares. Aurinia focuses on therapies for autoimmune kidney disease,...